Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic Cancer
Clinical trial NCT06789679 · RECRUITING
Trial details
- NCT number
- NCT06789679
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-25
- Primary completion
- 2026-06-30
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.